Almoosa Health Co. · TADAWUL:4018
Almoosa Health — Q3 2025 Earnings Presentation
36 slides from Almoosa Health's earnings presentation, November 2025
Slide 1: Almoosa Health Q3 2025 Earnings Presentation
Almoosa Health Q3 2025 Earnings Presentation November 2025
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Almoosa Health (the “Company”) for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investment activity, nor doe
Slide 3: Presenters & Agenda
Presenters & Agenda Malek Almoosa Chief Executive Officer 1 Business overview 2 Financial review Shailesh Chander Chief Financial Officer 3 Summary and outlook 4 Q&A Yousef Alyousef Investor Relations Officer 3
Slide 4: Business Overview
Business Overview Almoosa Health
Slide 5: Q3 2025 Highlights: Maintaining the growth trend
Q3 2025 Highlights: Maintaining the growth trend Revenue Earnings per Share Number of Clinics Q3 9M Q3 9M Q3/9M 356.4 MN 1 028.3 MN 1.17 3.50 356 +15.5% YoY +18.2% YoY +42.7% YoY +204.3% YoY EBITDA1 Net Profit Number of Available Beds Q3 9M Q3 9M Q3/9M 79.8 MN 232.7 MN 51.6 MN 154.5 MN 730 +11.3% Yo
Slide 6: Important agreements signed
Important agreements signed Global Health Agreement Signing Exhibition for Jubail Medical Center with Abdullah Al Othaim >130K visionaries gathered Investment Company At the Global Health Exhibition, A high-quality medical center Almoosa Health showcased not will expand Company’s footprint just grow
Slide 7: Agreement with Bnoon for Assisted Reproductive Technology services
Almoosa Health signed an agreement with Bnoon, leader in “Assisted Reproductive Technology” services Bnoon will be operating the IVF unit 5,000+ 45% at Almoosa Specialist Hospital IVF cycles done annually Success rates1 (1) For women below 35 years old. On par with International Success Rates 7
Slide 8: DRG Transformation Framework: gaining experience and marking the progress
DRG Transformation Framework: gaining experience and marking the progress Almoosa Health invested in team’s educational trip to Australia The team visited leading institutions and engaged with experts from both public and private sectors as well as national DRG authorities to study best practices in
Slide 9: A leader in comprehensive healthcare
A leader in comprehensive healthcare Almoosa offers a world-class integrated health system that fosters wellness and healing across the care continuum, enabled by innovation and transformation Primary Care1 Acute Care Post-acute Care Future offerings Aziziya Medical Center Rehabilitation Patient Acq
Slide 10: Medical Centers & Hospitals pipeline update
Delivering on our growth strategy: Medical Centers & Hospitals pipeline update Projects completed Projects in progress Projects yet to start Aziziya Q3 2025 Sulmaniyah Q2 2026 Specialist Q2 2027 Jubail Q4 2026 Medical Center Medical Center Hospital Medical Center Al-Khobar Al-Ahsa Al-Hofuf Jubail In
Slide 11: Nakheel Medical Center
Nakheel Medical Center Al-Ahsa 37 clinics JULY 30, 2025 Commencement of 6,100 m² Operations Built-up area Specializations’ list: Dermatology and cosmetic Optometry Primary Care Dental OB/GYN Emergency General Pediatrics Infusion center Pediatric endocrinology General surgery Allergy and immunology A
Slide 12: Aziziya Medical Center
Aziziya Medical Center Al-Khobar 38 clinics Specializations’ list: Primary Care 6,700 m² Dental Pediatrics Built-up area Dermatology OB/GYN Ophthalmology Hematology Pediatric Psychiatry Psychiatry Endocrinology Orthopedics Physiotherapy Commencement of Operations AUGUST 30, 2025 12
Slide 13: Sulmaniyah Medical Center
Sulmaniyah Medical Center Al-Ahsa 66 clinics Q2, 2026 Construction completion 16,800 m² Current Status: Built-up area • Construction • MOH • Testing and • CHI Commissioning • Staffing • Licenses Completed In-progress Specializations’ list: Pediatrics Neurology Dermatology Endocrinology OBS/GYN Ortho
Slide 14: Almoosa Specialist Hospital Al-Hofuf
Almoosa Specialist Hospital Al-Hofuf 200 clinics 300 beds 140,000 m² Q2 2027 Built-up area Construction completion Current Status: • Design • Construction • Enabling • Testing Works & Commissioning • Licenses • MoH • CHI • Staffing Completed In-progress Project Project Designer Consultant Supervisio
Slide 15: Almoosa Specialist Hospital Al-Khobar
Almoosa Specialist Hospital Al-Khobar 300 clinics 400 beds 300,000 m² Q1 2028 Built-up area Construction completion Current Status: • Design • Construction • Enabling • Testing & Works Commissioning • Licenses • MoH • CHI • Staffing Completed In-progress Project Project Enabling package Designer & C
Slide 16: Financial Review
Financial Review Almoosa Health
Slide 17: Q3 2025 Financial Highlights
Q3 2025 Financial Highlights 1 Steady revenue +15.5% Q3 2024 Δ% Q3 2025 increase across 356.4 MN MN segments YoY 15.5% Net Revenue 308.5 356.4 2 Robust EBITDA increase +11.2% 79.8 MN YoY 11.2% EBITDA1 71.7 -0.9 pp. 79.8 3 Strong Net Profit result +84.9% 51.6 MN (margin) 23.3% 22.4% YoY 84.9% Net Pro
Slide 18: 9M 2025 Financial Highlights
9M 2025 Financial Highlights 1 Resilient revenue +18.2% 9M 2024 Δ% 9M 2025 growth across 1 028.3 MN MN segments YoY +18.2% Net Revenue 870.2 1 028.3 2 Robust EBITDA increase +37.9% 232.7 MN YoY +37.9% EBITDA1 168.8 3.2 pp. 232.7 3 Strong Net Profit increase +282.6% 154.5 MN (margin) 19.4% 22.6% YoY
Slide 19: All segments contributing to robust performance
All segments contributing to robust performance Revenue by segment ( MN / %) Q3 2024 Q3 2025 Medical Services 63.8 227.7 78.5 230.8 % Change YoY 20.7% 73.8% 22.0% 64.8% Rehabilitation +1.4% Pharmaceuticals 17.0 308.5 MN +15.5% 356.4 MN +176.5% 5.5% 47.1 +23.0% 13.2% 9M 2024 9M 2025 193.2 230.8 597.9
Slide 20: Well-balanced payer mix
Well-balanced payer mix Revenue by payer mix ( MN / %) Q3 2024 Q3 2025 23.8 24.3 Insurance and corporates 261.6 6.7% 301.9 % Change YoY 7.9% 22.6 84.8% 30.7 84.7% Government 8.6% 7.3% +15.4% Cash 308.5 MN +15.5% 356.4 MN +35.7% -2.1% 9M 2024 9M 2025 65.4 67.9 7.3% 733.3 6.6% 871.6 % Change YoY 71.5
Slide 21: Strong profits and gradual margin increase
Strong profits and gradual margin increase supported by operational excellence and efficient capital structure Gross Profit / Margin ( MN / %) EBITDA1 / Margin ( MN / %) Net Profit / Margin ( MN / %) 31.8% 33.0% 28.9% 31.9% 23.3% 22.4% 19.4% 22.6% 9.1% 14.5% 4.6% 15.0% +30.4% +37.9% 328.3 232.7 +19.
Slide 22: Enhanced capital structure and debt optimization driving financial resilience
Enhanced capital structure and debt optimization driving financial resilience Shareholder Equity / Loan Balance Ratio 9M 2024 9M 2025 Shareholder Equity 25.6% 74.4% Loan 65.9% 34.1% Debt / EBITDA 5.5x 2.3x September, 30 September, 30 2025 2024 Debt / Equity 1.9x 0.3x Interest Coverage 1.7x 9.9x Sour
Slide 23: Outlook
Outlook Almoosa Health
Slide 24: 2025 & Medium-term guidance
2025 & Medium-term guidance 2024 2025 Medium-term1 Bed count # of Hospitals # of Medical Centers Revenue growth 1,430 beds 4 hospitals 6 Medical Centers 25%− 30% 2 hospitals 3 Medical Centers 20%−25% 730 beds 730 beds 2 hospitals 1 Medical Center 22.8% EBITDA margin Capex Leverage3 25%−30% 3,100MN2
Slide 25: Q&A
Q&A Almoosa Health
Slide 26: Appendix
Appendix Almoosa Health
Slide 27: Key investment highlights
Key investment highlights Tailwinds Integrated Favorable economic tailwinds boost the Company’s growth position in the 01 02 Offering a complete spectrum of services, from primary care to advanced defensive healthcare market rehabilitation, establishing Almoosa as a leader in comprehensive healthcar
Slide 28: Growing and underpenetrated healthcare sector relative to global benchmarks
Growing and underpenetrated healthcare sector relative to global benchmarks Notable historical acceleration in healthcare expenditures, Saudi healthcare expenditure as % of GDP driven by private sector with robust growth outlook is well behind global benchmarks Healthcare expenditures ( BN) CAGR 202
Slide 29: An integrated, patient-centered health system delivering continuity of care
An integrated, patient-centered health system delivering continuity of care Integrated Healthcare Ecosystem Preventative Primary Secondary Tertiary Post- Acute Care Tele-health Preventative Care Primary Care Acute Care Centers of Post-acute Care Tele-health Services Services Services Excellence Serv
Slide 30: Building a healthier future
Building a healthier future Environmental Social Governance Promoting environmental responsibility and building a greener future, through eco-friendly facilities Pioneering Sustainable Almoosa Health was among the pioneers in introducing green buildings in the KSA Architecture in Healthcare Waste Ma
Slide 31: Strong social record and commitment
Strong social record and commitment Environmental Social Governance Committed to invest in the society of Al-Ahsa as regional leader in community-based initiatives Saudi Arabia’s 95th National Day Cooking workshop A Paramedic in Every School A fun cooking activity during Al Nakheel Aims to train tea
Slide 32: Fostering balanced leadership and strategic insight
Fostering balanced leadership and strategic insight Environmental Social Governance Diverse governance structure ensures inclusive and effective decision-making across the organization Board of Directors Reporting system Oversight Risk Management Ethics and Integrity Diverse board composition Clear,
Slide 33: Income statement
Income statement MN Q3 2024 Q3 2025 % Chg. (Q3) 9M 2024 9M 2025 % Chg. (9M) Revenue 308.5 356.4 +15.5% 870.2 1 028.3 +18.2% Cost of revenue -210.4 -238.9 +13.6% -618.4 -700.0 +13.2% Gross profit 98.1 117.4 +19.8% 251.8 328.3 +30.4% General and administrative expenses -45.8 -58.6 +27.9% -132.3 -151.6
Slide 34: Balance sheet
Balance sheet MN FY 2024 Q3 2025 Property & equipment 1,894.4 2,238.7 Right of use assets 16.6 90.6 Intangible assets 8.4 9.9 Equity accounted investee 9.0 9.3 Total Non-Current Assets 1,928.4 2,348.6 Total Current Assets 625.0 858.0 Total Assets 2,553.4 3,206.5 Total Current Liabilities 562.8 438.7
Slide 35: Cash flow statement
Cash flow statement MN Q3 2024 Q3 2025 Net cash from operating activities 143.5 119.1 Net cash used in investing activities -172.5 -497.8 Net cash from financing activities 46.9 395.0 Net change in cash and cash equivalents 17.9 16.3 Cash and cash equivalents at beginning of the period 15.8 38.2 Cas
Slide 36: Thank you
Thank you ir.almoosahealthgroup.org